Skip to content

Dario™ Blood Glucose Monitoring System - User Performance Evaluation

Dario™ Blood Glucose Monitoring System - User Performance Evaluation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02053584
Enrollment
230
Registered
2014-02-03
Start date
2013-06-30
Completion date
2013-06-30
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The study is performed to evaluate the accuracy of blood glucose level results obtained from fingertip using Labstyle Dario Blood Glucose Monitoring System (BGMS) compared to reference equipment (YSI 2300 STATPLUS) and to evaluate the ease of use of the Dario Device by the lay-person. The participants will review the Dario user manual and guide and will be requested to operate the Dario BGMS and perform their own glucose blood test, after which they will be asked to complete a questionnaire. As reference the participants will be tested by professional caregivers both using the Dario BGMS and by YSI 2003.

Detailed description

Device accuracy will be assessed based on the acceptance criteria of ISO 15197:2003 which states: The minimum acceptable accuracy for results produced by a glucose monitoring system shall be as follows: 95% of the individual glucose results shall fall within 15 mg/dL of the results of Reference method at glucose concentrations ≥ 4,2 mmol/L (≥ 75 mg/dL).

Interventions

DEVICEDario™ Blood Glucose Meter

Each subject will undergo a finger prick and also provide a venous blood sample

DEVICEYSI2003

Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy.

Sponsors

LabStyle Innovations Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Healthy volunteers
No

Inclusion criteria

* Male or female between the age 18 and 80 * Type 1 and Type 2 diabetes

Exclusion criteria

* Drug and alcohol abuse * Investigator discretion

Design outcomes

Primary

MeasureTime frameDescription
BGMS Accuracy Assessment When Used by LaypersonWithin 6 seconds of applying blood drop to stripThe minimum acceptable accuracy for results produced by a glucose monitoring system shall be as follows: 95% of the individual glucose results shall fall within 15 mg/dL of the results of reference method (YSI) at glucose concentrations ≥ 4,2 mmol/L (≥ 75 mg/dL). (ISO 15197:2003)

Secondary

MeasureTime frameDescription
Evaluation of the Ease of Use of the Dario BGMS by the Lay-personWithin a couple of hours from the time labelling material was provided to the subjectEach participant receives a survey to fill in describing their usage of the device and their opinions on the ease of use.

Participant flow

Pre-assignment details

230 patients were consented, the patients from day one (n=68) were excluded from the final results analysis due to a number of technical issues.

Participants by arm

ArmCount
Dario BGMS
Dario™ Blood Glucose Meter: Each subject will undergo a finger prick and also provide a venous blood sample YSI2003: Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy.
161
Total161

Baseline characteristics

CharacteristicDario BGMS
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
66 Participants
Age, Categorical
Between 18 and 65 years
95 Participants
Age, Continuous55.5 years
STANDARD_DEVIATION 17.6
Region of Enrollment
Israel
161 participants
Sex: Female, Male
Female
97 Participants
Sex: Female, Male
Male
64 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 161
serious
Total, serious adverse events
0 / 161

Outcome results

Primary

BGMS Accuracy Assessment When Used by Layperson

The minimum acceptable accuracy for results produced by a glucose monitoring system shall be as follows: 95% of the individual glucose results shall fall within 15 mg/dL of the results of reference method (YSI) at glucose concentrations ≥ 4,2 mmol/L (≥ 75 mg/dL). (ISO 15197:2003)

Time frame: Within 6 seconds of applying blood drop to strip

ArmMeasureGroupValue (NUMBER)
Dario BGMSBGMS Accuracy Assessment When Used by Layperson>= 75 mg/dl Within ±5%44 percentage of participants
Dario BGMSBGMS Accuracy Assessment When Used by Layperson>= 75 mg/dl Within ±10%78 percentage of participants
Dario BGMSBGMS Accuracy Assessment When Used by Layperson>= 75 mg/dl Within ±15%126 percentage of participants
Dario BGMSBGMS Accuracy Assessment When Used by Layperson< 75 mg/dl Within ±5mg/dL2 percentage of participants
Dario BGMSBGMS Accuracy Assessment When Used by Layperson< 75 mg/dl Within ±10mg/dL4 percentage of participants
Dario BGMSBGMS Accuracy Assessment When Used by Layperson< 75 mg/dl Within ±15mg/dL6 percentage of participants
Dario BGMSBGMS Accuracy Assessment When Used by Layperson>= 75 mg/dl Within ±20%150 percentage of participants
Dario BGMSBGMS Accuracy Assessment When Used by Layperson>= 75 mg/dl155 percentage of participants
Secondary

Evaluation of the Ease of Use of the Dario BGMS by the Lay-person

Each participant receives a survey to fill in describing their usage of the device and their opinions on the ease of use.

Time frame: Within a couple of hours from the time labelling material was provided to the subject

ArmMeasureValue (NUMBER)
Dario BGMSEvaluation of the Ease of Use of the Dario BGMS by the Lay-person93 participants
Dario BGMS (Understood After Few Attempts)Evaluation of the Ease of Use of the Dario BGMS by the Lay-person67 participants
Dario BGMS (Did Not Understand How to Use)Evaluation of the Ease of Use of the Dario BGMS by the Lay-person1 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026